Why the study?
How does the Sabin strain of type 3 poliovirus evolve antigenically and molecularly during excretion by a primary vaccinee?
Population
A 4-month-old child immunized with a vaccine containing the Sabin live attenuated vaccine strains of all…
Design
Case_report
Follow-up
73 days
Authors
Loading...
Extended excretion of recombinant poliovirus strains may warrant surveillance vigilance; single case leaves open transmission risks.
How does the Sabin strain of type 3 poliovirus evolve antigenically and molecularly during excretion by a primary vaccinee?
The Sabin type 3 poliovirus vaccine strain undergoes rapid molecular evolution through recombination and point mutations during excretion in a primary vaccinee, while maintaining main immunodominant antigenic site stability.
Minor et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: